446 related articles for article (PubMed ID: 15454251)
1. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
[TBL] [Abstract][Full Text] [Related]
3. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
Lagergren P; Fayers P; Conroy T; Stein HJ; Sezer O; Hardwick R; Hammerlid E; Bottomley A; Van Cutsem E; Blazeby JM;
Eur J Cancer; 2007 Sep; 43(14):2066-73. PubMed ID: 17702567
[TBL] [Abstract][Full Text] [Related]
4. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
[TBL] [Abstract][Full Text] [Related]
5. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
6. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
Taphoorn MJ; Claassens L; Aaronson NK; Coens C; Mauer M; Osoba D; Stupp R; Mirimanoff RO; van den Bent MJ; Bottomley A;
Eur J Cancer; 2010 Apr; 46(6):1033-40. PubMed ID: 20181476
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care.
Suárez-del-Real Y; Allende-Pérez S; Alférez-Mancera A; Rodríguez RB; Jiménez-Toxtle S; Mohar A; Oñate-Ocaña LF
Psychooncology; 2011 Aug; 20(8):889-96. PubMed ID: 20662106
[TBL] [Abstract][Full Text] [Related]
8. Patients' acceptance and psychometric properties of the EORTC QLQ-CX24 after surgery.
Singer S; Kuhnt S; Momenghalibaf A; Stuhr C; Dimmel-Hennersdorf U; Köhler U; Einenkel J
Gynecol Oncol; 2010 Jan; 116(1):82-7. PubMed ID: 19836828
[TBL] [Abstract][Full Text] [Related]
9. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.
Cocks K; Cohen D; Wisløff F; Sezer O; Lee S; Hippe E; Gimsing P; Turesson I; Hajek R; Smith A; Graham L; Phillips A; Stead M; Velikova G; Brown J;
Eur J Cancer; 2007 Jul; 43(11):1670-8. PubMed ID: 17574838
[TBL] [Abstract][Full Text] [Related]
10. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer.
van Andel G; Bottomley A; Fosså SD; Efficace F; Coens C; Guerif S; Kynaston H; Gontero P; Thalmann G; Akdas A; D'Haese S; Aaronson NK
Eur J Cancer; 2008 Nov; 44(16):2418-24. PubMed ID: 18774706
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in patients with lung cancer: validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire.
Arrieta Ó; Núñez-Valencia C; Reynoso-Erazo L; Alvarado S; Flores-Estrada D; Angulo LP; Oñate-Ocaña LF
Lung Cancer; 2012 Jul; 77(1):205-11. PubMed ID: 22387006
[TBL] [Abstract][Full Text] [Related]
12. Validation of the polish version of the eortc QLQ-C30 and the QLQ-OG25 for the assessment of health-related quality of life in patients with esophagi-gastric cancer.
Tomaszewski KA; Püsküllüoğlu M; Biesiada K; Bochenek J; Nieckula J; Krzemieniecki K
J Psychosoc Oncol; 2013; 31(2):191-203. PubMed ID: 23514254
[TBL] [Abstract][Full Text] [Related]
13. The EORTC QLQ-C30 (version 3.0) Quality of Life questionnaire: validation study for Spain with head and neck cancer patients.
Arraras JI; Arias F; Tejedor M; Pruja E; Marcos M; Martínez E; Valerdi J
Psychooncology; 2002; 11(3):249-56. PubMed ID: 12112486
[TBL] [Abstract][Full Text] [Related]
14. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
[TBL] [Abstract][Full Text] [Related]
15. Health related quality of life in stem cell transplantation: clinical and psychometric validation of the questionnaire module, High Dose Chemotherapy (HDC-19).
Andersson I; Hjermstad M; Stockelberg D; Persson LO
Acta Oncol; 2008; 47(2):275-85. PubMed ID: 18210301
[TBL] [Abstract][Full Text] [Related]
16. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
Chaukar DA; Das AK; Deshpande MS; Pai PS; Pathak KA; Chaturvedi P; Kakade AC; Hawaldar RW; D'Cruz AK
Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
[TBL] [Abstract][Full Text] [Related]
17. Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery.
Singer S; Wollbrück D; Wulke C; Dietz A; Klemm E; Oeken J; Meister EF; Gudziol H; Bindewald J; Schwarz R
Head Neck; 2009 Jan; 31(1):64-76. PubMed ID: 18972411
[TBL] [Abstract][Full Text] [Related]
18. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
[TBL] [Abstract][Full Text] [Related]
19. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.
Chow E; Nguyen J; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bottomley A;
Cancer; 2012 Mar; 118(5):1457-65. PubMed ID: 21837676
[TBL] [Abstract][Full Text] [Related]
20. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
